TY - JOUR
T1 - Clinical trial awareness
T2 - Changes over time and sociodemographic disparities
AU - Leiter, Amanda
AU - Diefenbach, Michael A.
AU - Doucette, John
AU - Oh, William K.
AU - Galsky, Matthew D.
N1 - Funding Information:
M.D.G. is supported by a Prostate Cancer Foundation Young Investigator Award. M.A.D. is supported by the following awards from the National Cancer Institute: 1R01 CA158019-01, 1R21 CA155963, 1R21 CA164807, and W81XWH-11-1-0604, from the Department of Defense.
Publisher Copyright:
© The Author(s) 2015.
PY - 2015/6/11
Y1 - 2015/6/11
N2 - Background or aims: Lack of clinical trial awareness is a known obstacle to clinical trial enrollment. We sought to define the prevalence of clinical trial awareness in the US population, determine characteristics associated with increased trial awareness, and explore potential disparities in trial awareness. Methods: We utilized data from the Health Information National Trends Survey from 2008 and 2012. Logistic regression was utilized to assess predictors of clinical trial awareness, particularly sociodemographic variables and informationseeking preferences. Trial awareness and information-seeking preferences were compared in patient subgroups and between the two time periods. Results: Clinical trial awareness increased from 68% to 74% between 2008 and 2012. In the 2012 dataset, higher education level (odds ratio: 3.52, 95% confidence interval: 2.16?5.74), higher yearly income category (odds ratio: 1.84, 95% confidence interval: 1.17?2.89), and Internet use (odds ratio: 2.13, 95% confidence interval: 1.52?3.00) were significantly associated with clinical trial awareness. Hispanic ethnicity (odds ratio: 0.41, 95% confidence interval: 0.25?0.68) was significantly associated with decreased awareness. Clinical trial awareness increased in African-American/Blacks (D10.6%) and Hispanics (D10.7%) between 2008 and 2012, as did Internet use in both subgroups (D14.2%, D18.1%, respectively). Conclusion: Overall clinical trial awareness has increased between 2008 and 2012, although a large subset of the population still lacks general awareness of clinical trials. Racial and ethnic disparities in trial awareness exist, although disparities may be decreasing among the Black population. These findings may help target educational efforts and inform approaches to increasing trial awareness.
AB - Background or aims: Lack of clinical trial awareness is a known obstacle to clinical trial enrollment. We sought to define the prevalence of clinical trial awareness in the US population, determine characteristics associated with increased trial awareness, and explore potential disparities in trial awareness. Methods: We utilized data from the Health Information National Trends Survey from 2008 and 2012. Logistic regression was utilized to assess predictors of clinical trial awareness, particularly sociodemographic variables and informationseeking preferences. Trial awareness and information-seeking preferences were compared in patient subgroups and between the two time periods. Results: Clinical trial awareness increased from 68% to 74% between 2008 and 2012. In the 2012 dataset, higher education level (odds ratio: 3.52, 95% confidence interval: 2.16?5.74), higher yearly income category (odds ratio: 1.84, 95% confidence interval: 1.17?2.89), and Internet use (odds ratio: 2.13, 95% confidence interval: 1.52?3.00) were significantly associated with clinical trial awareness. Hispanic ethnicity (odds ratio: 0.41, 95% confidence interval: 0.25?0.68) was significantly associated with decreased awareness. Clinical trial awareness increased in African-American/Blacks (D10.6%) and Hispanics (D10.7%) between 2008 and 2012, as did Internet use in both subgroups (D14.2%, D18.1%, respectively). Conclusion: Overall clinical trial awareness has increased between 2008 and 2012, although a large subset of the population still lacks general awareness of clinical trials. Racial and ethnic disparities in trial awareness exist, although disparities may be decreasing among the Black population. These findings may help target educational efforts and inform approaches to increasing trial awareness.
KW - Clinical trial awareness
KW - Internet
KW - clinical trial barriers
KW - clinical trial disparities
KW - health communication
KW - health information
KW - national cross-sectional survey
UR - http://www.scopus.com/inward/record.url?scp=84929170669&partnerID=8YFLogxK
U2 - 10.1177/1740774515571917
DO - 10.1177/1740774515571917
M3 - Article
C2 - 25673636
AN - SCOPUS:84929170669
SN - 1740-7745
VL - 12
SP - 215
EP - 223
JO - Clinical Trials
JF - Clinical Trials
IS - 3
ER -